Diagnostic Kits/Disease Gene Patents - Revision history

AClearwater at 20:32, 10 September 2009

2009-09-10T20:32:05Z

← Older revision		Revision as of 20:32, 10 September 2009
Line 1:		Line 1:
			Merz, J.F., 1999. Disease Gene Patents: Overcoming Unethical Constraints on Clinical Laboratory Medicine. Clin Chem, 45(3), 324-330.(Merz 1999) Available at: http://www.clinchem.org/cgi/content/abstract/45/3/324 [Accessed August 5, 2009].

	*Merz, J.F., 1999 - The development of the genetic testing services market is investigated by Merz using three main factors. Merz claims market structure is primarily influenced by "the number of patents related to a test", "the simplicity of a test may favor pure competition", and "prevalence of a disease or condition." Merz is most concerned with the effect of patents on the market structure. Merz finds the solution to monopoly issues surrounding genetic testing services to be compulsory licensing. Merz concludes that "[c]ompulsory licensing is a reasonable compromise aimed at permitting laboratory medicine to proceed subject to payment of royalties, something all laboratories already do for use of methods such as PCR."		*Merz, J.F., 1999 - The development of the genetic testing services market is investigated by Merz using three main factors. Merz claims market structure is primarily influenced by "the number of patents related to a test", "the simplicity of a test may favor pure competition", and "prevalence of a disease or condition." Merz is most concerned with the effect of patents on the market structure. Merz finds the solution to monopoly issues surrounding genetic testing services to be compulsory licensing. Merz concludes that "[c]ompulsory licensing is a reasonable compromise aimed at permitting laboratory medicine to proceed subject to payment of royalties, something all laboratories already do for use of methods such as PCR."

AClearwater at 19:58, 10 September 2009

2009-09-10T19:58:58Z

← Older revision		Revision as of 19:58, 10 September 2009
Line 1:		Line 1:
	*Merz, J.F., 1999 - The development of the genetic testing services market is investigated by Merz using three main factors. Merz claims market structure is primarily influenced by "the number of patents related to a test", "the simplicity of a test may favor pure competition", and "prevalence of a disease or condition." Merz is most concerned with the effect of patents on the market structure. Merz finds the solution to monopoly issues surrounding genetic testing services to be compulsory licensing. Merz concludes that "[c]ompulsory licensing is a reasonable compromise aimed at permitting laboratory medicine to proceed subject to payment of royalties, something all laboratories already do for use of methods such as PCR."		*Merz, J.F., 1999 - The development of the genetic testing services market is investigated by Merz using three main factors. Merz claims market structure is primarily influenced by "the number of patents related to a test", "the simplicity of a test may favor pure competition", and "prevalence of a disease or condition." Merz is most concerned with the effect of patents on the market structure. Merz finds the solution to monopoly issues surrounding genetic testing services to be compulsory licensing. Merz concludes that "[c]ompulsory licensing is a reasonable compromise aimed at permitting laboratory medicine to proceed subject to payment of royalties, something all laboratories already do for use of methods such as PCR."

			==Navigation==
			[[Category:Diagnostic_Kits]]
			[[Main Page]]
			[[Diagnostic_Kits]]

AClearwater: New page: *Merz, J.F., 1999 - The development of the genetic testing services market is investigated by Merz using three main factors. Merz claims market structure is primarily influenced by "the n...

2009-09-10T19:43:39Z

New page: *Merz, J.F., 1999 - The development of the genetic testing services market is investigated by Merz using three main factors. Merz claims market structure is primarily influenced by "the n...

New page

*Merz, J.F., 1999 - The development of the genetic testing services market is investigated by Merz using three main factors. Merz claims market structure is primarily influenced by "the number of patents related to a test", "the simplicity of a test may favor pure competition", and "prevalence of a disease or condition." Merz is most concerned with the effect of patents on the market structure. Merz finds the solution to monopoly issues surrounding genetic testing services to be compulsory licensing. Merz concludes that "[c]ompulsory licensing is a reasonable compromise aimed at permitting laboratory medicine to proceed subject to payment of royalties, something all laboratories already do for use of methods such as PCR."